NDC 51662-1518
0.9% Sodium Chloride 900 mg per 100 mL injection, solution
On the label: HF Acquisition Co. LLC. DBA HealthFirst. It's repackaged: HF Acquisition Co. LLC. DBA HealthFirst rebottles it from ICU Medical Inc.'s NDC 0990-7983.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Hospira, Inc. | Rocky Mount, NC, United States | Makes it, tests it, packages it and labels it | No problems foundFeb 7, 2025 · 11 inspections, 3 with FDA action |
Repackaging site
- HF Acquisition Co LLC, Mukilteo, WA, United States · relabels it
Recalls
- Oct 27, 2025 · Class II · Otsuka ICU Medical LLC
Lack of Assurance of Sterility: Potential for flexible container leaks.
Lots: Lot # 1029921, Exp Date: 28 February 2027 - Nov 9, 2022 · Class II · ICU Medical Inc
Lack of assurance of sterility: Bags have the potential to leak in the flexible containers which may compromise sterility.
Lots: Lot: 5829936, Exp. MAR 31 2024
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Sodium Cation: every company that makes it
- Form
- injection, solution, intravenous
- Strength
- 900 mg per 100 mL
- Approval
- NDA NDA016366
- On the market since
- Apr 7, 2020
- Package NDCs
51662-1518-1- Official label
- DailyMed (National Library of Medicine), updated Apr 7, 2020
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?